調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Global Biologic Therapeutics Market 2015-2019

生物製剤治療の世界市場：タンパク質治療、ワクチン、細胞治療

◆タイトル：Global Biologic Therapeutics Market 2015-2019
◆商品コード：IRTNTR7720
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2015年10月21日
◆ページ数：104
◆資料形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD3,000 ⇒換算￥327,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算￥381,500見積依頼/購入/質問フォーム
Enterprise License（全社内共有可）USD4,500 ⇒換算￥490,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

当調査レポートでは、生物製剤治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、生物製剤治療の世界市場規模及び予測、種類別分析、需要先別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。

About biologic therapeutics
Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood components or derivatives, vaccines, blood, and proteins (except any chemically synthesized polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure. They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light.

Technavio’s analysts forecast the global biologic therapeutics market to grow at a CAGR of 8.26% over the period 2014-2019.

[Covered in this report]
This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).

Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Technavio’s report, Global Biologic Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global biologic therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• Americas
• APAC
• EMEA

[Key vendors]
• Amgen
• F. Hoffmann-La Roche
• Novo Nordisk
• Sanofi

[Other prominent vendors]
• AbbVie
• AstraZeneca
• Bavarian Nordic
• Baxter International
• Beijing Minhai Biotechnology
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• Bio Med Pvt.
• bioCSL
• Biodel
• Bristol-Myers Squibb
• Diamyd Medical
• DiaVacs
• Dynavax Technologies
• Eli Lilly
• Generex Biotechnology
• Hualan Biological Engineering
• Imunoloski Zavod
• Indian Immunologicals
• Janssen
• JN International Medical
• Kaketsuken
• LG Life Sciences
• Macrogenics
• MannKind
• Merck
• Mitsubishi Tanabe Pharma
• Nuron Biotech
• Osiris Therapeutics
• Pfizer
• Protalix
• Protein Sciences
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Tolerion
• Vacunas Finlay
• XOMA
• Zydus Cadila

[Market driver]
• Reimbursement support for biologics
• For a full, detailed list, view our report

[Market challenge]
• High cost of therapy
• For a full, detailed list, view our report

[Market trend]
• Emergence of targeted and combination therapies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by type of molecules

PART 07: Global protein therapeutics market
Introduction
Drivers, challenges, and trends
Market segmentation by type of molecules

PART 08: Global vaccines market
Introduction
Drivers, challenges, and trends
Market segmentation by end-user age group

PART 09: Global cell therapy market
Introduction
Drivers, challenges, and trends
Market size and forecast

PART 10: Geographical segmentation
Biologic therapeutics market in Americas
Biologic therapeutics market in EMEA
Biologic therapeutics market in APAC

PART 11: Market drivers
Reimbursement support for biologics
Promising drug pipeline
Focus on development of novel mechanisms
Increase in industry–academia collaborations

PART 12: Impact of drivers

PART 13: Market challenges
High cost of therapy
Stringent regulatory guidelines
Fierce market competition
Cold chain management
Poor diagnosis and screening

PART 14: Impact of drivers and challenges

PART 15: Market trends
Emergence of targeted and combination therapies
Increase in R&D
Shift in focus to untapped markets
Rise in public awareness

PART 16: Vendor landscape
Competitive scenario
Key news
Mergers and acquisitions
Market share analysis
Amgen
F. Hoffmann-La Roche
Novo Nordisk
Sanofi
Other and future prominent vendors

PART 17: Key vendor analysis
Amgen
F. Hoffmann-La Roche
Novo Nordisk
Sanofi

PART 18: Appendix
List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global biologic therapeutics market 2014-2019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global biologic therapeutics market segmentation by type of molecules
Exhibit 05: Global biologic therapeutics market segmentation by type of molecules 2014
Exhibit 06: Global biologic therapeutics market segmentation by type of molecules 2014-2019 ($ billions)
Exhibit 07: Key drivers and challenges of global protein therapeutics market
Exhibit 08: Key trends of global protein therapeutics market
Exhibit 09: Global protein therapeutics market 2014-2019 ($ billions)
Exhibit 10: Global protein therapeutics market 2014
Exhibit 11: Global protein therapeutics market by type of molecules 2014-2019 ($ billions)
Exhibit 12: Global monoclonal antibodies market 2014-2019 ($ billions)
Exhibit 13: Global enzymes market 2014-2019 ($ billions)
Exhibit 14: Global other protein therapeutics market 2014-2019 ($ billions)
Exhibit 15: Drivers of global vaccines market
Exhibit 16: Challenges of global vaccines market
Exhibit 17: Trends in global vaccines market
Exhibit 18: Global vaccines market 2014-2019 ($ billions)
Exhibit 19: Global vaccines market by end-user age group 2014
Exhibit 20: Global vaccines market by end-user age group 2014-2019 ($ billions)
Exhibit 21: Global pediatric vaccines market 2014-2019 ($ billions)
Exhibit 22: Global adult vaccines market 2014-2019 ($ billions)
Exhibit 23: Key factors influencing the global cell therapy market
Exhibit 24: Global cell therapy market 2014-2019 ($ billions)
Exhibit 25: Global biologic therapeutics market by geography 2014
Exhibit 26: Biologic therapeutics market in Americas 2014-2019 ($ billions)
Exhibit 27: Biologic therapeutics market in EMEA 2014-2019 ($ billions)
Exhibit 28: Biologic therapeutics market in APAC 2014-2019 ($ billions)
Exhibit 29: Global biologic therapeutics market by geography 2014-2019 ($ billions)
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Revenue of Enbrel 2012-2014 ($ millions)
Exhibit 33: Revenue of Epogen 2012-2014 ($ millions)
Exhibit 34: Revenue of Neulasta/Neupogen 2012-2014 ($ millions)
Exhibit 35: Revenue of vectibix 2012-2014 ($ millions)
Exhibit 36: Revenue of Xgeva 2012-2014 ($ millions)
Exhibit 37: Revenue of Prolia 2012-2014 ($ millions)
Exhibit 38: Revenue of Avastin 2012-2014 ($ millions)
Exhibit 39: Revenue of Kadcyla 2013 and 2014 ($ millions)
Exhibit 40: Revenue of Lucentis 2012-2014 ($ millions)
Exhibit 41: Revenue of Rituxan/MabThera 2012-2014 ($ millions)
Exhibit 42: Revenue of Pegasys 2012-2014 ($ millions)
Exhibit 43: Revenue of Perjeta 2013 and 2014 ($ millions)
Exhibit 44: Revenue of Pulmozyme 2012-2014 ($ millions)
Exhibit 45: Revenue of Pulmozyme 2012-2014 ($ millions)
Exhibit 46: Revenue of Apridra 2012-2014 ($ millions)
Exhibit 47: Revenue of Cerezyme 2012-2014 ($ millions)
Exhibit 48: Revenue of Fabrazyme 2012-2014 ($ millions)
Exhibit 49: Revenue of Myozyme/Lumizyme 2012-2014 ($ millions)
Exhibit 50: Revenue of Lantus 2012-2014 ($ millions)
Exhibit 51: Revenue of Zaltrap 2012-2014 ($ millions)
Exhibit 52: Amgen: Business segmentation by revenue 2014
Exhibit 53: Amgen: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 54: Amgen: Geographical segmentation by revenue 2014
Exhibit 55: Novo Nordisk: Business segmentation by revenue 2014
Exhibit 56: Novo Nordisk: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 57: Novo Nordisk: Geographical segmentation by revenue 2014
Exhibit 58: Novo Nordisk: R&D expenditure 2014
Exhibit 59: Business segmentation by revenue 2013 and 2014 ($ billions)



【掲載企業】

Amgen, F. Hoffmann-La Roche, Novo Nordisk, Sanofi.

【資料のキーワード】

生物製剤治療、モノクローナル抗体、酵素、小分子、タンパク質治療、ワクチン、細胞治療、医療

【調査方法】

一次資料による調査（業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など）及び二次資料による調査（Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど）

★調査レポート[生物製剤治療の世界市場：タンパク質治療、ワクチン、細胞治療] (Global Biologic Therapeutics Market 2015-2019 / IRTNTR7720)販売に関する免責事項
[生物製剤治療の世界市場：タンパク質治療、ワクチン、細胞治療] (Global Biologic Therapeutics Market 2015-2019 / IRTNTR7720)についてEメールでお問い合わせ
◆関連調査資料◆
  • 整形外科用軟組織修復装置の世界市場2017-2021：細胞治療、組織スキャフォールド、固定装置
    IRTNTR13876 / Technavio / 2017年8月28日 / Technavio社が発行した当調査レポートでは、整形外科用軟組織修復装置の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、整形外科用軟組織修復装置の世界市場規模及び予測、用途別分析、製品別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。Technavio社は整形外科用軟組織修復装置の世界市場が2017-2021年期間中に年平均10.32%成長すると予測しています。当レポート上に記載されている主な企業はArthrex、Stryker、Zimmer Biomet等です。...About Orthopedic Soft Tissue Repair DevicesOrthopedic soft tissues are masses of cells that connect, support, or surround bones. Orthopedic soft tissues can include tendons, ligaments, cartilage, fascia, skin, fat, and other fibrous tissues. Accidents, injuries, or degeneration of these tissues with age can result in wear and tear. Tissue damage can be repaired using orthopedic soft tissue repair devices. The repair of orthopedic soft tissues is done either by open surgical procedures or through minimally invasive (MI) procedures, such as arthroscopy. The treatment of orthopedic soft tissue damage has evolved in the past decade. Reparative and restorative methods have been...
  • 軟組織修復の世界市場2017-2021：細胞治療、組織スキャフォールド、軟組織固定デバイス
    IRTNTR12233 / Technavio / 2017年3月13日 / 当調査レポートでは、軟組織修復の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、軟組織修復の世界市場規模及び予測、用途別分析、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Soft Tissue Repair Soft tissue repair market consists of cell therapy-based products, tissue scaffolds, and soft tissue fixation devices and accessories. Cell therapy and tissue scaffold products are developed through bioengineering, which requires extensive funding to conduct R&D and clinical trials. Hence, support from the governments in developed countries will encourage various large and small companies to develop novel technology. Technavio’s analysts forecast the global soft tissue repair market to grow at a CAGR of 13.32% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global soft tissue...
  • 蛋白質治療の世界市場2017-2021：mAbs、ヒトインスリン、凝固因子、EPO、ヒト成長ホルモン
    IRTNTR11316 / Technavio / 2016年12月29日 / 当調査レポートでは、蛋白質治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、蛋白質治療の世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Protein TherapeuticsTherapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer-related anemia. Therapeutic proteins mostly consist of recombinant forms of naturally occurring proteins. Technavio’s analysts forecast the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021. [Covered in this report] The report covers the present...
  • 再生医療の世界市場：細胞治療、組織スキャフォールド、遺伝子治療
    IRTNTR9465 / Technavio / 2016年5月16日 / 当調査レポートでは、再生医療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、再生医療の世界市場規模及び予測、用途別分析、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。...About the Regenerative Medicine Market Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products. Technavio’s analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020. [Covered in this report] The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020....
  • 免疫治療薬の世界市場：モノクローナル抗体、免疫チェックポイント阻害薬、ワクチン、非特異的免疫療法
    IRTNTR8772 / Technavio / 2016年3月29日 / 当調査レポートでは、免疫治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、免疫治療薬の世界市場規模及び予測、種類別分析、用途別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。...About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders. Technavio’s analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period 2016-2020. [Covered in this report] The report covers the present scenario and the growth prospects of the global immunotherapy drugs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunotherapy drugs used to...
  • 肝臓病治療の世界市場：非アルコール性脂肪性肝疾患、肝硬変、肝癌、肝炎
    IRTNTR7566 / Technavio / 2015年9月30日 / 当調査レポートでは、肝臓病治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、肝臓病治療の世界市場規模及び予測、種類別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About liver diseases Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections, alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using...
  • 子宮頸がん治療薬の世界市場2015-2019
    IRTNTR7066 / Technavio / 2015年9月9日 / 当調査レポートでは、子宮頸がん治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、子宮頸がん治療薬の世界市場規模及び予測、種類別分析、用途別分析、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular check-ups. Vaginal bleeding and pelvic pain are usually observed as signs and...
  • 再生医療の世界市場：小分子・生物製剤、細胞治療、遺伝子治療
    IRTNTR4861 / Technavio / 2014年12月17日 / 当調査レポートでは、再生医療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、再生医療の世界市場規模及び予測、用途別分析、技術別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Regenerative Medicines Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, cell therapy, and gene therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues. Whereas cell therapy helps in treating the functioning of the existing cells, gene therapy helps in the correction of defective genes of the body....
  • 生物学的製剤の世界市場：タンパク質治療薬、ワクチン、細胞治療薬
    IRTNTR4486 / Technavio / 2014年10月29日 / ...About Biologic Therapeutics Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogenicity. Biologic products are generally characterized by high molecular weight and complex structures. These products are usually derived from living entities and are less easily characterized compared to small molecules. These products are...
  • 世界の動物医療市場：診断、薬、ワクチン、飼料添加物
    IRTNTR3924 / Technavio / 2014年8月20日 / ...About Animal Health Animal health refers to veterinary services intended to prevent animal diseases or treat animals to enhance their quality of life, increase their lifetime, or increase the yield of animal food. The Global Animal Health market covers the following segments: Feed Additives, Pharmaceuticals, Vaccines, and Diagnostics. Animal feed additives improve the health of animals and the quality of animal food. Animal pharmaceuticals and animal vaccines are used to treat or prevent a disease/condition. Animal diagnostics help in the detection of bacteria, antibodies, viruses, and hormones. TechNavio's analysts forecast the Global Animal Health market to grow at a CAGR...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆